2,4-diphenyl-6-[3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)[1,1'-biphenyl]-3-yl]-1,3,5-Triazine, 97%, 5g

o-Tolylboronic acid (contains varying amounts of anhydride), 99.00%, 200g

1-(2-BROMO-3-CHLOROPHENYL)ETHANONE, 95.0%, 10g

2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, hydrochloride (1:2), 98%, 100mg

exo-3,6-Epoxy-1,2,3,6-tetrahydrophthalic Anhydride>98.0%(T)100g

[(5-tert-butyl-1,3-benzoxazol-2-yl)methyl]amine hydrochloride, 95.0%, 5g

7-Fluoroindole, 97.0%, 25g

1,5-Dibromo-3-methylpentane, 97%, 10g

Methyl 2-amino-3,5-dibromo-4-methoxybenzoate, 97%, 1g

1-Boc-4-Formyl-4-methylpiperidine, 95.0%, 10g

Fmoc-L-Isoleucina, PEPTIPURE®, mínimo 98 %, para bioquímica, 250 g, envase de vidrio

1,4-Bis((1H-1,2,4-triazol-1-yl)methyl)benzene, 98%, 250mg

1-[2-(2-Trifluoromethyl-phenyl)-thiazol-4-yl]-ethanone, 95.0%, 1g